Castle Biosciences, Inc. (NASDAQ:CSTL – Get Free Report) shares traded down 4.7% during mid-day trading on Tuesday . The company traded as low as $21.90 and last traded at $22.12. 111,875 shares traded hands during mid-day trading, a decline of 54% from the average session volume of 240,997 shares. The stock had previously closed at […]

Related Keywords

Daniel Bradbury , Derekj Maetzold , Zurcher Kantonalbank Zurich Cantonalbank , Robertw Baird , Castle Biosciences , Pricet Rowe Associates Inc , Keycorp , Millrace Asset Group Inc , Scotiabank , Assetmark Inc , Castle Biosciences Inc , Nasdaq , Securities Exchange Commission , Get Free Report , Director Daniel Bradbury , Exchange Commission , Kantonalbank Zurich Cantonalbank , Millrace Asset Group , Asset Group , Mypath Melanoma , Castle Biosciences Daily ,